Details for New Drug Application (NDA): 075500
✉ Email this page to a colleague
NDA 075500 describes SORINE, which is a drug marketed by Aiping Pharm Inc and is included in one NDA. It is available from two suppliers. Additional details are available on the SORINE profile page.
The generic ingredient in SORINE is sotalol hydrochloride. There are ten drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the sotalol hydrochloride profile page.
The generic ingredient in SORINE is sotalol hydrochloride. There are ten drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the sotalol hydrochloride profile page.
Summary for 075500
| Tradename: | SORINE |
| Applicant: | Aiping Pharm Inc |
| Ingredient: | sotalol hydrochloride |
| Patents: | 0 |
Pharmacology for NDA: 075500
| Mechanism of Action | Adrenergic beta-Antagonists |
| Physiological Effect | Cardiac Rhythm Alteration |
Medical Subject Heading (MeSH) Categories for 075500
Suppliers and Packaging for NDA: 075500
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| SORINE | sotalol hydrochloride | TABLET;ORAL | 075500 | ANDA | AiPing Pharmaceutical, Inc. | 11788-051 | 11788-051-01 | 100 TABLET in 1 BOTTLE (11788-051-01) |
| SORINE | sotalol hydrochloride | TABLET;ORAL | 075500 | ANDA | AiPing Pharmaceutical, Inc. | 11788-052 | 11788-052-01 | 100 TABLET in 1 BOTTLE (11788-052-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 80MG | ||||
| Approval Date: | Apr 27, 2001 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 160MG | ||||
| Approval Date: | Apr 27, 2001 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 240MG | ||||
| Approval Date: | Apr 27, 2001 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
